Lanean...
SGLT2 inhibition to address the unmet needs in diabetic nephropathy
Current treatment of diabetic nephropathy is effective; however, substantial gaps in care still remain and new therapies are urgently needed to reduce the global burden of the complication. Desirable properties of an “ideal” new drug should include primary prevention of microalbuminuria, additive/sy...
Gorde:
| Argitaratua izan da: | Diabetes Metab Res Rev |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
John Wiley and Sons Inc.
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6849789/ https://ncbi.nlm.nih.gov/pubmed/30997935 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dmrr.3171 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|